[1]陈 博,李 涛.清热消滞抗癌方联合放疗对食管癌患者4-羟基壬烯醛、糖类抗原199的影响[J].陕西中医,2022,(12):1749-1752.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.023]
　CHEN Bo,LI Tao.Effects of Qingre Xiaozhi Kang'ai decoction combined with radiotherapy on levels of 4-HNE and CA199 in patients with esophageal cancer[J].,2022,(12):1749-1752.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.023]
点击复制

清热消滞抗癌方联合放疗对食管癌患者4-羟基壬烯醛、糖类抗原199的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年12期
页码:
1749-1752
栏目:
临床研究
出版日期:
2022-12-20

文章信息/Info

Title:
Effects of Qingre Xiaozhi Kang'ai decoction combined with radiotherapy on levels of 4-HNE and CA199 in patients with esophageal cancer
作者:
陈 博1; 李 涛2
(1.成都市中西医结合医院,四川 成都 610041; 2.四川省肿瘤医院,四川 成都 610041)
Author(s):
CHEN Bo; LI Tao
(Chengdu Integrated TCM Western Medicine Hospital,Chengdu 610041,China)
关键词:
食管癌;  痰气交阻证;  清热消滞抗癌方;  放疗;  4-羟基壬烯醛;  糖类抗原199
Keywords:
Esophageal carcinoma;  Tanqi Jiaozu syndrome;  Qingre Xiaozhi Kang'ai decoction;  Radiotherapy;  4-hydroxynonenal;  Carbohydrate antigen 199
分类号:
R 735.1
DOI:
DOI:10.3969/j.issn.1000-7369.2022.12.023
文献标志码:
A
摘要:
目的:探究清热消滞抗癌方联合放疗对食管癌(EC)痰气交阻证患者外周血4-羟基壬烯醛(4-HNE)、糖类抗原199(CA199)的影响。方法:选取105例EC痰气交阻证患者为研究对象,采用随机信封法分为研究组(n=52)、对照组(n=53)。对照组采用单纯放疗,研究组在对照组的基础上联合清热消滞抗癌方加减治疗,两组患者均治疗7周。比较两组患者治疗后中医临床疗效。比较两组治疗前和治疗后中医证候积分、氧化应激指标[4-HNE、丙二醛(MDA)]、血清肿瘤标志物[CA199、鳞状上皮细胞癌抗原(SCC)、人细胞角蛋白21-1片段(CYFRA21-1)],以及两组患者治疗期间的不良反应发生情况。结果:治疗后,研究组总有效率94.2%,明显高于对照组患者的81.1%,差异有统计学意义(P<0.05)。治疗后,两组患者中医证候积分、血清CA199、SCC、CYFRA21-1水平均较治疗前降低,且研究组低于对照组,差异有统计学意义(均P<0.05)。治疗后,两组患者4-HNE、MDA均较治疗前升高,且对照组高于研究组,差异有统计学意义(均P<0.05)。治疗期间,研究组发生放射性肺炎、放射性食管炎者均低于对照组,差异有统计学意义(均P<0.05)。结论:清热消滞抗癌方联合放疗可改善EC患者临床症状,降低血清肿瘤标志物水平,减轻因放疗造成的氧化应激反应,且不良反应少。
Abstract:
Objective:To explore effects of Qingre Xiaozhi Kang'ai decoction combined with radiotherapy on 4-hydroxynonenal(4-HNE)and carbohydrate antigen 199(CA199)in peripheral blood of patients with esophageal carcinoma(EC)of Tanqi Jiaozu syndrome.Methods:105 patients with EC of Tanqi Jiaozu syndrome were selected as study subjects,and they divided into study group(n=52)and control group(n=53)by the random envelope method.The control group were treated with radiotherapy alone,while the study group were combined with Qingre Xiaozhi Kangai decoction on the basis of the control group.Both groups were treated for 7 weeks.The clinical TCM efficacy was compared between the two groups after 7 weeks of treatment.TCM symptom score,oxidative stress [4-HNE,malondialdehyde(MDA)] and serum tumor markers [CA199,squamous cell carcinoma antigen(SCC),human cytokeratin 21-1 fragment(CYFRA21-1)] were recorded before treatment and after 7 weeks of treatment.The occurrence of adverse reactions of radiotherapy during treatment in the two groups were recorded.Results:After 7 weeks of treatment,the total effective rate 94.2% in the study group was significantly higher than that in the control group 81.1%,difference statistically significant(P<0.05).The score of TCM symptom and levels of serum CA199,SCC and CYFRA21-1 in the two groups after treatment were reduced compared with those before treatment,and they were lower in the study group than those in the control group,difference statistically significant(all P<0.05).The levels of 4-HNE and MDA in both groups were enhanced after treatment compared to before treatment,they were lower in the study group than those in the control group,difference statistically significant(all P<0.05).During treatment,the severity of radiation pneumonitis and radiation esophagitis were significantly milder in the study group than those in the control group(P<0.05).Conclusion:Qingre Xiaozhi Kang'ai decoction combined with radiotherapy can improve clinical symptoms of patients with EC,reduce the levels of serum tumor markers,and relieve oxidative stress response caused by radiotherapy,with mild adverse reactions.

参考文献/References:

[1] 温珊珊,王品鸽,刘 聪,等.不同靶区照射的三维适形放疗对老年食管癌的疗效和及对血清标志物影响及预后分析[J].实用癌症杂志,2022,37(5):840-843.
[2] 南新记,栗广辉,王志峰.利膈散联合顺铂方案治疗食管癌效果及对患者炎性因子、生活质量和不良反应的影响[J].陕西中医,2019,40(1):58-60.
[3] 陈宏宏,王海鹰.老年中晚期食道癌患者行紫杉醇同步放疗对疗效与安全性的影响[J].贵州医药,2021,45(2):206-207.
[4] 张 森,何威华,华 松,等.扶正消瘤汤对食管癌患者放疗前后临床症状、细胞免疫功能及外周血细胞凋亡的影响[J].陕西中医,2018,39(11):1511-1514.
[5] 张 丹,肖 平.生态翻译观视域下李照国译《黄帝内经》的适应性选择分析及启示[J].湖南中医药大学学报,2019,39(1):138-142.
[6] 陈玉龙,张 瑞,郑玉玲.食管癌辨治学术思想及经验撷英[J].中华中医药杂志,2022,37(2):835-838.
[7] 任明名,王俊壹,李 柳,等.癌毒病机理论辨治食管癌探讨[J].中华中医药杂志,2022,37(2):839-842.
[8] 张合林,石彦涛,刘瑞林.食管恶性肿瘤诊疗技术[M].北京:科学技术文献出版社,2013.
[9] 王永炎.中医内科常见病诊疗指南[M].北京:中国中医药出版社,2008:63-64.
[10] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:77.
[11] 邓 玲.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:54.
[12] 邓颖妮,何志旭.肿瘤干细胞在食管鳞状细胞癌中的研究进展[J].中华肿瘤防治杂志,2022,29(4):240-247.
[13] 许若煊,李冬斌,张 旭,等.食管癌致病因素及对预后影响的研究进展[J].河北医药,2022,44(10):1556-1560,1565.
[14] 巢元方.诸病源候论[M].北京:中国医药科技出版社,2011:42.
[15] 严用和.重辑严氏济生方[M].北京:中国中医药出版社,2020:53.
[16] 戴原礼.秘传证治要诀及类方[M].北京:中国医药科技出版社,2020:39.
[17] 查永嫱,孙东东,潘立群.食管癌术后中医药治疗研究进展[J].南京中医药大学学报,2019,35(6):767-770.
[18] 何若瑜,赵智强.周仲瑛教授辨治食管癌、胃癌异同探析[J].辽宁中医药大学学报,2014,16(11):107-108.
[19] 李路路,陈 剑,张鼎儒,等.四君子汤合沙参麦冬汤加减联合IMRT放疗治疗局部复发食管鳞癌的疗效和安全性[J].现代肿瘤医学,2020,28(21):3734-3736.
[20] 马婷婷,张甘霖,张博然,等.半枝莲和白花蛇舌草药对的研究现状[J].中华中医药杂志,2021,36(6):3491-3494.
[21] 余 莹,胡 玲,劳绍贤.基于网络药理学探讨漏芦治疗胃癌的作用机制[J].中华中医药学刊,2020,38(12):65-68.
[22] 权浩浩,张晓凤,高 凯,等.基于网络药理学的僵蚕主要药效作用研究[J].西部中医药,2021,34(3):92-96.
[23] 薛 贝,李富增,吕思缘,等.王成祥教授采用扶正化痰解毒法治疗肺癌经验撷萃[J].世界中西医结合杂志,2022,17(2):268-271,298.
[24] 倪 峰,徐 健,邰国梅,等.复方苦参注射液联合放疗治疗老年中晚期食管癌临床疗效及对患者血清CEA、CA199及CA50水平的影响[J].湖北中医药大学学报,2022,24(1):38-41.

相似文献/References:

[1]南新记,栗广辉,王志峰.利膈散联合顺铂方案治疗食管癌效果及对患者炎性因子、生活质量和不良反应的影响*[J].陕西中医,2019,(1):58.
　NAN Xinji,LI Guanghui,WANG Zhifeng..Effect of Ligesan combined with cisplatin regimen on esophageal cancer patients and its effects on inflammatory factors, quality of life and adverse reactions[J].,2019,(12):58.
[2]张广健,李益行,范 坤,等.肠功能恢复汤深部保留灌肠对食管癌术后患者肠功能恢复的疗效研究[J].陕西中医,2022,(11):1560.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.016]

备注/Memo

备注/Memo:
基金项目:四川省人社厅科研项目(2017JY0307)
更新日期/Last Update: 2022-12-09